NORTH
CHICAGO, Ill., Feb. 28,
2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will
participate in the Cowen 43rd Annual Health Care Conference on
Tuesday, March 7, 2023. Robert A. Michael, vice chairman and president,
Scott Reents, executive vice
president, chief financial officer, Jeffrey
R. Stewart, executive vice president, chief commercial
officer and Roopal Thakkar, senior
vice president, development and regulatory affairs and chief
medical officer, will present at 8:10 a.m.
Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology and gastroenterology, in
addition to products and services across its Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us at
www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram,
YouTube and LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-cowen-43rd-annual-health-care-conference-301757985.html
SOURCE AbbVie